Key result
Baseline platelet activity was higher in young adults with acute ischemic stroke compared to healthy controls.
Why the study?
Ischemic stroke is a major health concern in younger populations, and the study evaluated whether platelet activity and reactivity are risk factors to inform stricter antiplatelet protocols for management and recurrence prevention.
Are platelet activity and reactivity elevated in young adults with acute ischemic non-embolic stroke compared to healthy controls?
Case-Control (n=120)
No
Are platelet activity and reactivity elevated in young adults with acute ischemic non-embolic stroke compared to healthy controls?
Baseline platelet activity and reactivity are significantly elevated in young adults with acute ischemic stroke, suggesting a role in atherothrombotic pathophysiology.
Answers are grounded in this paper and cite their sources.
Elevated CD62P expression associates with non-embolic ischemic stroke in young adults; hypothesis-generating and should not yet change practice.
Background Ischemic stroke (IS) constitutes a relevant health concern recently in younger population causing permanent cognitive and function-limiting disability and ranks as the 3rd cause of death in Egypt after cardiac and hepatic diseases. Platelet activation has a crucial mechanism in arterial thrombogenesis, thus in pathophysiology of IS. Surface expression of P-selectin (CD62P) reflects platelet activation and measured by flowcytometry. The purpose of the study is to evaluate whether platelet activity and reactivity are considered risk factors for IS so more restrict antiplatelet protocols could be implemented for management and recurrence prevention. Results Study population was 60 IS patients and 60 apparently healthy age and gender-matched controls. Patients were subdivided into 37 patients without classical risk factors, aged 46.1 ± 8.2, and 23 patients with > 1 vascular risk factors, aged 52 ± 9.9. The percentage of platelets expressing CD62P reflecting ex vivo baseline activity was significantly higher in stroke patients to controls (p = 0.001), also platelet reactivity (CD62P expression after ADP provocation) was statistically significantly elevated in patients than in controls (p < 0.0001) and was significantly higher in IS patients with vascular risk factors compared to patients without risk factors (p = 0.02). Conclusion Both baseline platelet activity and reactivity were significantly higher in IS patients, and were also higher in IS patients with other vascular risk factors than in cryptogenic stroke and considered risk factors for IS.
No takes yet. Share an insight, caveat, or question.
Nashaat et al. (2021) conducted a case-control in Acute non-embolic ischemic stroke (n=120). Acute non-embolic ischemic stroke vs. Healthy controls was evaluated on Baseline platelet activity (percentage of platelets expressing CD62P) (p=0.001). Baseline platelet activity was higher in young adults with acute ischemic stroke compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: